EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?

Kathryn A Seely, Paul L Prather, Laura P James, Jeffery H Moran

Molecular Interventions · 01.02.2011 · 11 (1) · 36-51

DOI: 10.1124/mi.11.1.6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Interventions, online erschienen am 24.03.2011. Verfasst von Kathryn A Seely und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Die Arbeit wurde bisher 109-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The principal psychoactive component of marijuana, Δ(9)-tetrahydrocannabinol (THC), activates CB1 cannabinoid receptors (CB1Rs). Unfortunately, pharmacological research into the design of effective THC analogs has been hampered by psychiatric side effects. THC-based drug design of a less academic nature, however, has led to the marketing of "synthetic marijuana," labeled as K2 or "Spice," among other terms, which elicits psychotropic actions via CB1R activation. Because of structural dissimilarity to THC, the active ingredients of K2/Spice preparations are widely unregulated. The K2/Spice "phenomenon" provides a context for considering whether marijuana-based drugs will truly provide innovative therapeutics or merely perpetuate drug abuse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCannabinoidsCannabisClinical Trials as TopicDesigner DrugsHumansIllicit DrugsModels, Biological

Substanzen

CannabinoidsDesigner DrugsIllicit Drugs

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Förderung

  • NCRR NIH HHS

Zitieren

APA

Seely, K. A., Prather, P. L., James, L. P., & Moran, J. H. (2011). Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?. Molecular Interventions, 11(1), 36-51. https://doi.org/10.1124/mi.11.1.6

Vancouver

Seely KA, Prather PL, James LP, Moran JH. Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?. Molecular Interventions. 2011;11(1):36-51. doi:10.1124/mi.11.1.6

BibTeX
@article{Seely2011,
  author = {Seely, Kathryn A and Prather, Paul L and James, Laura P and Moran, Jeffery H},
  title = {Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?},
  journal = {Molecular Interventions},
  year = {2011},
  volume = {11},
  number = {1},
  pages = {36--51},
  doi = {10.1124/mi.11.1.6}
}
Kostenlos starten →